Comparative analysis of regional outcomes and adverse events after continuous-flow left ventricular assist device implantation: An IMACS analysis.

[1]  J. Cowger,et al.  Third Annual Report From the ISHLT Mechanically Assisted Circulatory Support Registry: A comparison of centrifugal and axial continuous-flow left ventricular assist devices. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  M. Walsh,et al.  A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report , 2019, The New England journal of medicine.

[3]  M. Morshuis,et al.  Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry , 2018, European heart journal.

[4]  A. Haverich,et al.  The momentum of HeartMate 3: a novel active magnetically levitated centrifugal left ventricular assist device (LVAD). , 2018, Journal of thoracic disease.

[5]  R. Hetzer,et al.  The European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardio-Thoracic Surgery (EACTS): second report , 2018, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[6]  M. Martínez‐Sellés,et al.  Clinical outcomes of temporary mechanical circulatory support as a direct bridge to heart transplantation: a nationwide Spanish registry , 2018, European journal of heart failure.

[7]  W. Cohn,et al.  Impact of Body Mass Index on Implantation of a Continuous-Flow Left Ventricular Assist Device: Single-Center 508 Patient Experience , 2017 .

[8]  Robert L Kormos,et al.  Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  T. Nishinaka,et al.  Japanese registry for Mechanically Assisted Circulatory Support: First report. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[10]  M. Hannan,et al.  An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[11]  Finn Gustafsson,et al.  Left ventricular assist device therapy in advanced heart failure: patient selection and outcomes , 2017, European journal of heart failure.

[12]  C. Bara,et al.  (197) - Impact of Body Mass Index on Left Ventricular Assist Device Support , 2017 .

[13]  A. Israni,et al.  OPTN/SRTR 2015 Annual Data Report: Heart , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  D. Mancini,et al.  The Impact of Obesity on Patients Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices. , 2016, JACC. Heart failure.

[15]  M. Ono,et al.  Japanese Multicenter Outcomes With the HeartMate II Left Ventricular Assist Device in Patients With Small Body Surface Area. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[16]  J. Morgan,et al.  Effect of Body Mass Index on Outcomes in Left Ventricular Assist Device Recipients , 2016, Journal of cardiac surgery.

[17]  Takeshi Nakatani,et al.  First Annual IMACS Report: A global International Society for Heart and Lung Transplantation Registry for Mechanical Circulatory Support. , 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  C. Caldeira,et al.  Incidence and Risk Factor Analysis for Gastrointestinal Bleeding and Pump Thrombosis in Left Ventricular Assist Device Recipients. , 2015, Artificial organs.

[19]  M. Morshuis,et al.  The European Registry for Patients with Mechanical Circulatory Support (EUROMACS): first annual report. , 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[20]  D. Mancini,et al.  Report From a Forum on US Heart Allocation Policy , 2015, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[21]  J. Kobashigawa,et al.  Left ventricular assist device in patients with body mass index greater than 30 as bridge to weight loss and heart transplant candidacy. , 2014, Transplantation proceedings.

[22]  N. Chou,et al.  The influence of the organ allocation policy on a patient's chances of undergoing heart transplantation and the posttransplantation survival rate. , 2012, Transplantation proceedings.

[23]  Theresa McDonagh,et al.  UK guidelines for referral and assessment of adults for heart transplantation , 2011, Heart.

[24]  R. Hetzer,et al.  Body mass index and outcome after ventricular assist device placement. , 2008, The Annals of thoracic surgery.

[25]  T. Imaizumi,et al.  Special report from the heart transplant candidate registry committee in Japan. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[26]  S. Adatya,et al.  Quality of life and functional capacity outcomes in the MOMENTUM 3 trial at 6 months: A call for new metrics for left ventricular assist device patients. , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[27]  Nader Moazami,et al.  Unexpected abrupt increase in left ventricular assist device thrombosis. , 2014, The New England journal of medicine.

[28]  R. Pierson,et al.  Body Mass Index and Outcomes After Left Ventricular Assist Device Placement , 2005 .